Skip to content
Main Navigation
About us
Company profile
Our values
Our strategy
Board of Directors
Senior management
Our history
Research and development
Technology platform
Therapeutic areas
Pipeline
Scientific papers and presentations
Partnering
Our approach
Our partnerships
Investors
Financial reports and presentations
Share information
Analyst coverage
Major shareholders
Financial calendar
Corporate governance
Corporate governance statements
Dividend policy
Annual general meeting
Articles of association
Safe harbour statement
Whistleblower policy
Risk management
Investor relations policy
ESG
Email alerts
Newsroom
Press Releases
Image library
Glossary
Email alerts
Careers
Life at Nykode
Meet us
Open positions
Search
Investors
Financial reports and presentations
Latest company presentation (PDF)
Newest first
Oldest first
Presentations
Financial reports
Webcasts
Search
Reset
10/05/2017
QUARTERLY REPORT – 2017 Q1
02/03/2017
QUARTERLY REPORT – 2016 Q4
22/11/2016
QUARTERLY REPORT- 2016 Q3
29/08/2016
QUARTERLY REPORT-2016 Q2
25/08/2016
Vaccibody announces positive results from the phase I part of the clinical trial VB C-01 in patients with high-grade cervical dysplasia and recommendation by the cohort review committee as well as the independent data monitoring board to continue to the expansion phase (IIa)
Pages:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Load more
Sorry, nothing found in this query
Privacy statement
Cookie policy
Disclaimer
